SCHEMBL484361

SCHEMBL484361

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccc6nccnc6c5)CC4)C3)cc21)c1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.40
USP2 O75604 13/20 0.40
CYP3A4 P08684 12/20 0.40
TSHR P16473 6/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
CYP2C9 P11712 4/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2D6 P10635 5/20 0.39
CYP1A2 P05177 4/20 0.39
CYP2C19 P33261 3/20 0.39
HIF1A Q16665 2/20 0.39
MCHR2 Q969V1 1/20 0.38
ENPP2 Q13822 1/20 0.38
ATXN2 Q99700 1/20 0.38
CRHR1 P34998 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485083 0.96 CYP3A4 (0.45) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL484671 0.93 CCR3 (0.42) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL484593 0.90 MRGPRX4 (0.40) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL484785 0.89 ACKR3 (0.40) CYP3A4TSHRCYP2C9ALDH1A1CYP2D6
SCHEMBL484812 0.89 USP2 (0.42) USP2CYP3A4TSHRSMN1; SMN2CYP2C9
SCHEMBL2817961 0.89 MRGPRX4 (0.37) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL484910 0.88 USP2 (0.52) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL2818735 0.87 CRHR1 (0.40) MRGPRX4USP2CYP3A4TSHRSMN1; SMN2
SCHEMBL484675 0.87 CYP3A4 (0.55) USP2CYP3A4TSHRSMN1; SMN2CYP2C9
SCHEMBL485317 0.87 ACKR3 (0.39) USP2CYP3A4TSHRCYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN MRGPRX4 24/4885USP2 4864/4885CYP3A4 3781/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN MRGPRX4 24/4885USP2 4864/4885CYP3A4 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.